Thermogel Delivers Oxaliplatin and Alendronate in situ for Synergistic Osteosarcoma Therapy

The therapeutic effect of osteosarcoma (OS) has not made extraordinary progress in the past few decades. Oxaliplatin (OXA) is a widely used clinical anti-tumor drug. Recent studies have shown that OXA can trigger anti-tumor immunity by inducing immunogenic death (ICD). Alendronate (ALN) has been use...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yifu, Li, Ke, Li, Chen, Zhang, Ying, Zhao, Duoyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523411/
https://www.ncbi.nlm.nih.gov/pubmed/33042974
http://dx.doi.org/10.3389/fbioe.2020.573962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523411/
https://www.ncbi.nlm.nih.gov/pubmed/33042974
http://dx.doi.org/10.3389/fbioe.2020.573962

Ejemplares similares